Verkazia 1 mg/mL eye drops, emulsion
LT1695-201
Phase 2 small_molecule active
Quick answer
Verkazia 1 mg/mL eye drops, emulsion for Vernal Keratoconjunctivitis (VKC) is a Phase 2 program (small_molecule) at Laboratoire HRA Pharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Laboratoire HRA Pharma
- Indication
- Vernal Keratoconjunctivitis (VKC)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active